Bubbly biochemistry: Understanding the components of sparkling wine
Whether or not your holiday celebrations involve imbibing, the cultural link between champagne flutes and festivities is strong. The fizz and pop of sparkling wine give breaking out the bubbly a special pizzazz.

In the first glycoproteomics study of its kind, a research team in the journal Molecular & Cellular Proteomics that glycoproteins are an important part of keeping those bubbles in solution. Cassandra Pegg and colleagues at the University of Queensland put a variety of sparkling wines under the microscope — or, more accurately, into the mass spectrometer — in hopes that the work would lead to better wine-making methods.
“Sparkling wine is really difficult to pipette,” Pegg, a postdoctoral researcher in Ben Schulz’s lab, said. “We have had some sets of samples that were gushing” — that’s a wine-biz term for when bubbles won’t stay in solution — “and the tubes would pop open in the lab.”
Gushing, when champagne or cava comes foaming out of an opened bottle, entertained Pegg and her colleagues. But it’s less than desirable commercially: Winemakers want the dissolved gas to come out of solution slowly, making a beverage that continues to bubble until it’s finished.
Sparkling wine’s carbonation results from two rounds of fermentation. After producing a base wine, winemakers mix in a solution of yeast and sugar and seal it all into a bottle to trap the carbon dioxide the yeast produce. The yeast strain, grape blend and tweaks to the production process can affect the quality of the final product — but the process is often a matter of trial and error.
To understand more about molecular attributes leading to positive prosecco properties, the researchers degassed samples of sparkling wine that had been aged for different periods or fermented with different strains of yeast. They used proteomic and glycoproteomic techniques to characterize the brews. Wine doesn’t have much protein, and most of the proteins they found were secreted by yeast or found in their cell walls. A surprisingly high proportion were glycosylated, or modified with complex sugar molecules.

As wines age, their proteins and glycopeptide constituents change. According to Ben Schulz, the professor who led the work, changes late in the aging process, when “no biology should be happening,” probably depend on the biophysics of protein solubility. Glycosylation can make a peptide more water-soluble and less likely to clump into sediment.
Similar principles may guide a wine’s propensity to gush. Researchers that a yeast cell wall protein called seripauperin 5 can stabilize foam; this and related proteins were among the most abundant that Schulz’s team identified.
“It’s not completely understood,” Schulz said of the protein’s foam-stabilizing effect. “But from a biophysical standpoint, it makes sense: Glycans tend to be hydrophilic, and peptides hydrophobic.” By clustering at the interfaces between liquid and gas, small glycopeptides could affect a wine’s surface tension and change the rate at which dissolved gas coalesces into bubbles and escapes.
By understanding the production methods that affect seripauperin 5 and other glycoproteins, Schulz said, he hopes to work in the future with winemakers looking to optimize their products.
Enjoy reading 91影库Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91影库Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.